← Brennan Habetler

What podcasts say about Brennan Habetler

Every statement, with the speaker, the exact quote and the moment it was said.

What Brennan Habetler has said on podcasts

7 statements · 4 positive · 3 negative

  1. ElectroMed revenue grew at approximately 15% annually over five years.

    “revenue increasing on a very consistent basis with a compound and annual growth rate kegger at 15 over the past five years”

    Listen at 28:11

    Open the episode · Stock Talk Podcast Episode 352
  2. ElectroMed’s share count has declined because repurchases exceeded issuance.

    “the share count has actually declined as the company has bought back more shares than it's issued”

    Listen at 28:46

    Open the episode · Stock Talk Podcast Episode 352
  3. ElectroMed’s fiscal 2026 fourth-quarter revenue growth slowed meaningfully.

    “It is a meaningful slowdown.”

    Listen at 29:28

    Open the episode · Stock Talk Podcast Episode 352
  4. ElectroMed’s fiscal 2027 growth is expected to be low double-digit.

    “I would expect low double-digit growth compared to the 15.3% for fiscal 2026.”

    Listen at 32:10

    Open the episode · Stock Talk Podcast Episode 352
  5. ElectroMed’s reliance on SmartVest creates material product concentration risk.

    “the reliance on one product, SmartVest. This creates a concentration risk.”

    Listen at 32:32

    Open the episode · Stock Talk Podcast Episode 352
  6. Medicare and Medicaid reimbursement changes could materially affect ElectroMed.

    “Medicare and Medicaid changes can meaningfully impact Electromed.”

    Listen at 32:46

    Open the episode · Stock Talk Podcast Episode 352
  7. ElectroMed is an appealing long-term investment.

    “Overall, ElectroMed is an appealing investment.”

    Listen at 35:03

    Open the episode · Stock Talk Podcast Episode 352

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.